Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
03/09/2005 | CN1590367A Preparation method of L-ornithine hydrochloride |
03/09/2005 | CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same |
03/09/2005 | CN1192035C Inhibitors of interleukin-1'beta' converting enzyme |
03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
03/08/2005 | US6864390 Antiepileptic agents; central nervous system disorders; psychological disorders |
03/03/2005 | WO2005019158A1 1-carbamoylcycloalkylcarboxylic acid compounds, processes fro making and uses thereof |
03/03/2005 | WO2004092119A3 Method for producing alpha-methylated cysteine and serine derivatives |
03/03/2005 | US20050049432 Reacting gabapentin hydrochloride with amine; salt formation ; distilaltion |
03/03/2005 | US20050049387 A polyethyleneimine or polylysine copolymerized polyurea containing multiple ether groups when complexed with polynucleotides form useful transfection reagents |
03/03/2005 | CA2535616A1 1-carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof |
03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
03/02/2005 | EP1509491A1 Intermediate products, methods for their preparation and use thereof |
03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
03/02/2005 | EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
03/02/2005 | EP1392650B1 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2- ?18 f]-fluoroethyl)-l-tyrosine |
03/02/2005 | EP1155023B1 Chelating compounds and their complexes with paramagnetic metals |
03/02/2005 | EP1151130B1 Coenzyme useful for the synthesis of l-carnitine |
03/02/2005 | EP1042279B1 Substituted beta-alanines |
03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
03/02/2005 | CN1589257A N-methyl-homocysteines and their use as well as process for their production |
03/02/2005 | CN1587257A Process for preparing amino acid chelated calcium and its special device |
03/02/2005 | CN1587256A Method for producing chloropropham |
03/02/2005 | CN1587252A Multiple photon absorptive phenyl fluorene derivative and its preparing method |
03/02/2005 | CN1191232C Aminomethylcarboxylic acid derivatives |
03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
03/01/2005 | US6861448 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment |
03/01/2005 | US6861391 Pesticides and herbicides |
03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
03/01/2005 | CA2288334C Method of manufacturing sertindole |
02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
02/24/2005 | US20050043565 Methods for producing substituted acrylic acid esters and use of the latter for producing substituted $G (G)-amino acids |
02/24/2005 | US20050043547 Process for producing optically active azetidine-2-carboxylic acids |
02/24/2005 | US20050043541 five-coordinate metal complex, a salt, a solvate or an enantiomer comprising a carbene ligand, a multidentate ligand and a constraint steric hindrance ligand having a pKa of >15; high activity at moderate temperatures; narrow molecular weight distribution addition polymers; unsaturation reactions |
02/24/2005 | US20050043509 Peptoid compounds |
02/24/2005 | US20050043454 Water-base composition and crosslinking agent for water-soluble polymers |
02/24/2005 | US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
02/24/2005 | DE10331481A1 Verfahren zur Reduzierung der Formaldehyd- und Cyanid-Gehalte in Lösungen von Sarkosinsalzen A method for reducing the formaldehyde and cyanide contents in solutions of Sarkosinsalzen |
02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
02/23/2005 | EP1507523A1 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease |
02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
02/23/2005 | CN1583715A Method for preparing related aminoacetic acid from benzaldehyde and its derivative |
02/23/2005 | CN1190413C Production of EDTA complex metal salt |
02/22/2005 | US6858753 Reacting a nickel source, an iodine source, and a ligand in a solvent under carbon monoxide atmosphere to obtain an in situ catalyst complex, contacting a mixture of aliphatic alcohol and carbon monoxide with the complex to perform carbonylation |
02/22/2005 | US6858748 Treatment of colon cancer |
02/22/2005 | US6858688 Amino acid complexes and the use thereof in producing olefin polymers |
02/22/2005 | US6858650 Stable salts of novel derivatives of 3,3-diphenylpropylamines |
02/22/2005 | US6858575 Michael Addition reaction product of a primary and/or secondary amine compound with an unsaturated ester, acid or nitrile perfume compound. Pro-perfumes made from this selected type of reaction product provide a desirable and |
02/22/2005 | US6858434 Using thin layer chromatography for rapid preparation and screening of lead structures for drug candidates; rational drug design |
02/22/2005 | US6858396 Amino acids where primary amine group is replaced by azide; use in peptides screening for bioactivity, crossing blood-brain barrier, increasing selectivity; treating brain disorders |
02/17/2005 | WO2005014528A1 Straight-chain and branched-chain lipid compounds as selective inhibitors of cyclooxygenase-2, anti-inflammatory agents, and anti-cancer agents |
02/17/2005 | WO2005014527A1 Anaqueous solution of a sodium salt of hedta |
02/17/2005 | WO2004014682A8 A vehicle and a vehicle door |
02/17/2005 | US20050038122 Phenyl naphthol ligands for thyroid hormone receptor |
02/17/2005 | US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion |
02/17/2005 | US20050038084 Phenylalanine enamide derivatives |
02/16/2005 | EP1506955A1 Bicyclic amino acids as pharmaceuticals agents |
02/16/2005 | EP1506210A2 Ascorbyl derivatives of carnitines for cosmetic compositions containing same |
02/16/2005 | EP1506168A2 Gelling agents |
02/16/2005 | EP1506162A2 Synthesis of benzonitriles and benzimidates |
02/16/2005 | EP1506159A1 Method for producing 2-(4-n, n-dialkylamino-2-hydroxybenzoyl)benzoates |
02/16/2005 | EP1506154A1 Process for the preparation of a n,n-diamino amino acid-beta-hydroxy disuccinic acid |
02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
02/16/2005 | CN1580039A Method for synthesizing dichlofenac sodium |
02/16/2005 | CN1580037A Symmetrical fluorene derivatives with multi proton absorption |
02/16/2005 | CN1579445A Effective-component extract of Foliun-Mori and its preparation method |
02/16/2005 | CN1189447C Process for synthesizing 6-18F-L-dopa |
02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
02/15/2005 | US6855702 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
02/15/2005 | CA2405466C Method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
02/10/2005 | US20050033086 Chemical intermediates for statins |
02/10/2005 | US20050032775 Aztreonam L-lysine and methods for the preparation thereof |
02/10/2005 | US20050031541 Diagnosis and treatment of cervical and bladder cancer using hexyl 5-aminolevulinate as a photosensitizer; improved photochemotherapeutic properties; antineoplastic agents |
02/09/2005 | EP1427704B1 Method for producing 4-haloalkylnicotinic acid esters |
02/09/2005 | EP1313560A4 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION |
02/09/2005 | CN1576270A Process for extracting lysine by ion exchange method |
02/09/2005 | CN1576269A N-<l- deoxyglucose alcoho1-1-radical> amino acid and producing process and use thereof |
02/09/2005 | CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF |
02/08/2005 | US6852876 Treatment of colon cancer |
02/08/2005 | US6852854 Preformed carboxylated active ester for labeling biomolecules |
02/08/2005 | US6852755 This invention pertains to nitrogen mustard compounds (Formula (II)) and prodrugs therefor (Formula (I)), methods for their preparation, pharmaceutical compositions comprising such compounds, and the use of such compounds and |
02/08/2005 | US6852750 Spinal cord injury, demyelinating diseases, Parkinson's disease, Amyotrophic Lateral Sclerosis, alcohol, nicotine, cocaine dependence, neuropathy, pain and schizophrenia; antiischemic, - carcinogenic agents; NAALADase inhibitors |
02/03/2005 | WO2005010011A2 Methods of synthesis of acyloxyalkyl compounds |
02/03/2005 | WO2005009969A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
02/03/2005 | WO2005009928A2 Preparation and use of alkylating agents |
02/03/2005 | WO2005009104A2 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators |
02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
02/03/2005 | US20050027119 Methyl (2S)-2-(2,3,4-trifluoroanilino)propionate from 2,3,4-trifluoroaniline and an acetic acid ester in the presence of a metal catalyst under a hydrogen gas; antibacterial agents |
02/03/2005 | US20050027013 LTA4 hydrolase inhibitors |
02/03/2005 | US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
02/03/2005 | CA2538520A1 Preparation and use of alkylating agents |
02/02/2005 | EP1501801A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
02/02/2005 | EP1501784A1 Intergrated chemical processes for industrial utilization of seed oils |
02/02/2005 | EP1501491A2 Methods and compositions for treatment of cancer pain |
02/02/2005 | CN1575274A Production of keto acids |
02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
02/02/2005 | CN1187329C Preparation method of 3-oxyindole derivative for synthesizing indigo |
02/02/2005 | CN1187328C Method for synthesizing indigo by using N-substituted glycine or glycine ester |